search
Back to results

Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC (MIRACLE)

Primary Purpose

Ulcerative Colitis

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Multi-interventional program
Sponsored by
London North West Healthcare NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Ulcerative Colitis focused on measuring ileoanal pouch, IPAA, pouch, ulcerative colitis, leak

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of Ulcerative Colitis
  • Diagnosis of Crohn's disease limited to the colon without any history of perianal disease
  • Modified two or three stage restorative proctocolectomy
  • Age above 18
  • Able to fill in questionnaires in local language and to come to out-patient-clinic visits;

Exclusion Criteria:

  • Known allergy to ICG, or iodide allergy.
  • Pregnancy
  • Redo pouch operation
  • Age under 18

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    No Intervention

    Other

    Arm Label

    Historic cohort

    Multi-interventional program cohort

    Arm Description

    Outcomes

    Primary Outcome Measures

    Leak rate
    Anastomotic integrity at one year postoperatively defined as the absence of presacral collections, anastomotic fistula and severe anastomotic stricture (not amenable for digital dilatation by rectal exam).

    Secondary Outcome Measures

    Cumulative anastomotic dehiscence rate
    Anastomotic insufficiency at 30 days, 6 months and 12 months defined as contrast extravasation and/or presacral perianastomotic fluid collections on CT scan or Anastomotic dehiscence at endoscopy.
    QOL
    Quality of life and functional outcomes preoperatively and then 3, 6, 12 and 18 months post-operatively.
    Protocol compliance
    Protocol compliance to any intervention
    ICG
    Change in management due to ICG
    CRP
    Diagnostic accuracy of CRP for anastomotic leakage
    EVAC
    Efficacy of EVAC with early transanal closure of the anastomotic defect
    Stoma rate
    Permanent stoma rate at 18 months
    Temporary ileostomy rate and duration
    Temporary stoma rate and stoma duration at 18 months
    Complications
    Operative and post-operative complications within 30 days and 12 months (cumulative) of operation (using the Clavien-Dindo classification of surgical complications)
    Death
    Death
    Hospital stay
    Hospital stay and total hospital stay at one year
    Reintervention rate
    Reintervention rate
    Readmission
    Overall and stoma-related readmission
    Cost analysis of EVAC
    Cost analysis of anastomotic leakage and EVAC therapy

    Full Information

    First Posted
    June 23, 2021
    Last Updated
    June 23, 2021
    Sponsor
    London North West Healthcare NHS Trust
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04939025
    Brief Title
    Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC
    Acronym
    MIRACLE
    Official Title
    Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2021
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    July 1, 2021 (Anticipated)
    Primary Completion Date
    July 1, 2022 (Anticipated)
    Study Completion Date
    August 1, 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    London North West Healthcare NHS Trust

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    The objective of this quality improvement project is to increase the one year anastomotic integrity rate in patients having had completion proctectomy and pouch reconstruction for Ulcerative Colitis by the routine and quality controlled implementation of a multi-interventional program thereby improving long-term pouch function and survival.
    Detailed Description
    Ulcerative colitis is an inflammatory bowel disorder that affects predominantly young patients interfering with their social, family and professional life's (Ungaro, Mehandru, Allen, Peyrin-Biroulet, & Colombel, 2017). When the disease is moderate to severe, it is difficult to control medically even in the era of the biologic treatment. Colectomy rates are reported to be as high as 50% after 5 years in patients admitted with a severe exacerbation (Duijvis et al., 2016; Thorne et al., 2016). In a modified two (colectomy first followed by completion proctectomy and pouch) or three stage procedure (colectomy first followed by completion proctectomy and pouch with diverting ileostomy, finally stoma closure) a proctocolectomy is done and continuity can be restored with a ileoanal pouch (Sahami, Buskens, et al., 2016; Zittan et al., 2016). These are the preferred options for the majority of our patients. Alternatives are proctocolectomy with definitive end-ileostomy or a continent ileostomy. Quality of life of patients with pouches depends predominantly on proper function of the pouch. Inadequate function and long term pouch failure are determined by the occurrence of chronic anastomotic leaks, chronic pouchitis and a delayed diagnosis of Crohn's disease in and around the pouch (Lightner et al., 2017). The latter two diagnoses, Crohn's disease and chronic pouchitis are in an important number in fact misdiagnosed chronic leaks (Garrett et al., 2009; van der Ploeg, Maeda, Faiz, Hart, & Clark, 2017). Long-term pouch failure rates (pouch excision or secondary diversion of the pouch) add up to more than 1 out of 10 at 10 years (Ikeuchi et al., 2018; Lightner et al., 2017; Mark-Christensen et al., 2018). These data represent the results of expert centers, so real life data are probably worse. Chronic leaks are late sequalae leaking anastomosis which has been inadequately treated; misdiagnosed or diagnosed too late to treat successfully. Although many centers publish more favorable figures, the true rate of anastomotic leakage of ileoanal pouches probably varies from 10-20% (Sahami, Bartels, et al., 2016; Sossenheimer et al., 2019; Widmar et al., 2019). There is an important underreporting of the leaks. If the pouch is diverted, the leak will only become apparent prior to ileostomy closure when the anastomosis is tested. Even testing the anastomosis is not 100% accurate accounting for a number of misdiagnosed leaks. These misdiagnosed and delayed diagnosed leaks are generally not included in series reporting short term results (Santorelli, Hollingshead, & Clark, 2018; Sossenheimer et al., 2019; Widmar et al., 2019). For all these reasons it is of great importance to prevent anastomotic leakage when creating a ileoanal pouch and if it happens, to solve the problem as soon as possible. Numerous risk factors have been identified for anastomotic leakage. The most important factors are tension on the anastomosis, inadequate vascularization of the pouch, an unfavorable microbiome and the use of immunosuppressive drugs (steroids, immunomodulators, biologic treatments). By staging the restorative proctocolectomy, the negative impact of immunosuppressive drugs on anastomotic healing are avoided because at the time of the pouch creation the drugs are weaned for a long period. Other factors including anastomotic technique and anastomotic perfusion are modifiable surgical factors. A more recently described pathophysiological mechanism relates to the intestinal microbiome (Alverdy, Hyoju, Weigerinck, & Gilbert, 2017). Apparently, this holds true for small bowel surgery as well (Lesalnieks, Hoene, Bittermann, Schlitt, & Hackl, 2018). Proper management of a leak comprises early diagnosis and immediate and adequate management. Sequential CRP measurement and early investigation of the integrity of the anastomosis are key for early diagnosis, particularly in a diverted anastomosis which might not be symptomatic (Adamina et al., 2015; Warschkow et al., 2012). The current management of the leak usually involves a diverting ileostomy, if not performed primarily, in combination with passive drainage of the abscess cavity via transanal or transcutaneous route. This approach showed to be relatively ineffective leading to a pouch failure rate of 20%, and if resolved to a worse pouch function (Garrett et al., 2009; Lightner et al., 2017). Endosponge vacuum assisted closure (EVAC) of the anastomotic leak on the contrary showed to have a very high success rate and to prevent long-term pouch dysfunction and failure (Bemelman & Baron, 2018; Gardenbroek et al., 2015; Verlaan et al., 2011; Weidenhagen, Gruetzner, Wiecken, Spelsberg, & Jauch, 2008). There is minimal risk to patients as there is no introduction of a novel technique, rather this study is an amalgamation of published improvements in pouch surgery pre, intra and post-operatively to reduce the leak rate at one year.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Ulcerative Colitis
    Keywords
    ileoanal pouch, IPAA, pouch, ulcerative colitis, leak

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Sequential Assignment
    Model Description
    The MIRACLE study is an international multicenter clinical effectiveness study, whereby the current local practice (control cohort) will be evaluated, and subsequently compared to the results after implementation of the multi-interventional program (intervention cohort).
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    50 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Historic cohort
    Arm Type
    No Intervention
    Arm Title
    Multi-interventional program cohort
    Arm Type
    Other
    Intervention Type
    Procedure
    Intervention Name(s)
    Multi-interventional program
    Intervention Description
    Preoperative oral antibiotics and antibiotic enema of the rectal stump prior to the surgery Routine and tailored lengthening measures of the mesentery Intraoperative control of pouch vascularization using ICG Early diagnosis and active assessment of the integrity of the anastomosis. Routine CRP-measurements at day 4 and 6 (after removal pouch catheter) in the non-diverted pouches with CT-scan with rectal contrast if any suspicion on a leak (elevated or rise in CRP. symptoms). Routine CRP-measurements at day 4 in the diverted pouches with endoscopy 10-14 days after pouch creation. Endosponge vacuum assisted closure (EVAC) of the anastomotic defect aiming to close the defect within 10-14 days after diagnosis. MRI assessment of the pouch after stoma closure preferably at one year to rule out chronic sepsis mimicking pouchitis or Crohn's disease.
    Primary Outcome Measure Information:
    Title
    Leak rate
    Description
    Anastomotic integrity at one year postoperatively defined as the absence of presacral collections, anastomotic fistula and severe anastomotic stricture (not amenable for digital dilatation by rectal exam).
    Time Frame
    1 year
    Secondary Outcome Measure Information:
    Title
    Cumulative anastomotic dehiscence rate
    Description
    Anastomotic insufficiency at 30 days, 6 months and 12 months defined as contrast extravasation and/or presacral perianastomotic fluid collections on CT scan or Anastomotic dehiscence at endoscopy.
    Time Frame
    18 month
    Title
    QOL
    Description
    Quality of life and functional outcomes preoperatively and then 3, 6, 12 and 18 months post-operatively.
    Time Frame
    3,6,12 and 18 months
    Title
    Protocol compliance
    Description
    Protocol compliance to any intervention
    Time Frame
    18 month
    Title
    ICG
    Description
    Change in management due to ICG
    Time Frame
    Operative
    Title
    CRP
    Description
    Diagnostic accuracy of CRP for anastomotic leakage
    Time Frame
    30 days
    Title
    EVAC
    Description
    Efficacy of EVAC with early transanal closure of the anastomotic defect
    Time Frame
    18 month
    Title
    Stoma rate
    Description
    Permanent stoma rate at 18 months
    Time Frame
    18 month
    Title
    Temporary ileostomy rate and duration
    Description
    Temporary stoma rate and stoma duration at 18 months
    Time Frame
    18 month
    Title
    Complications
    Description
    Operative and post-operative complications within 30 days and 12 months (cumulative) of operation (using the Clavien-Dindo classification of surgical complications)
    Time Frame
    1 year
    Title
    Death
    Description
    Death
    Time Frame
    1 year
    Title
    Hospital stay
    Description
    Hospital stay and total hospital stay at one year
    Time Frame
    1 year
    Title
    Reintervention rate
    Description
    Reintervention rate
    Time Frame
    18 month
    Title
    Readmission
    Description
    Overall and stoma-related readmission
    Time Frame
    18 month
    Title
    Cost analysis of EVAC
    Description
    Cost analysis of anastomotic leakage and EVAC therapy
    Time Frame
    18 month

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Diagnosis of Ulcerative Colitis Diagnosis of Crohn's disease limited to the colon without any history of perianal disease Modified two or three stage restorative proctocolectomy Age above 18 Able to fill in questionnaires in local language and to come to out-patient-clinic visits; Exclusion Criteria: Known allergy to ICG, or iodide allergy. Pregnancy Redo pouch operation Age under 18
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Mohammed Deputy
    Phone
    +447958395012
    Email
    m.deputy@nhs.net

    12. IPD Sharing Statement

    Learn more about this trial

    Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC

    We'll reach out to this number within 24 hrs